» Authors » Hassan Mobayed

Hassan Mobayed

Explore the profile of Hassan Mobayed including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 25
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Mobayed H, Al-Nesf M, Robles-Velasco K, Cherrez-Ojeda I, Ensina L, Maurer M
Front Allergy . 2023 Aug; 4:1228495. PMID: 37577331
Exercise-induced anaphylaxis (EIA) is a rare disorder in which anaphylaxis occurs exclusively after physical activity. Here, we report a case of severe EIA where anaphylaxis was initially only induced by...
12.
Maurer M, Abuzakouk M, Al-Ahmad M, Al-Herz W, Alrayes H, Al-Tamemi S, et al.
World Allergy Organ J . 2023 Jan; 16(1):100729. PMID: 36601261
Background: Hereditary angioedema (HAE), a potentially life-threatening genetic disorder due to C1 inhibitor deficiency in most cases, is characterized by sudden and/or recurrent attacks of angioedema (subcutaneous/submucosal swellings). The global...
13.
Ibrahim Y, Bin Naji S, Mobayed H, Al-Nesf M
Qatar Med J . 2022 Aug; 2022(2):7. PMID: 35968518
Specialist nurses have a crucial role within the allergy and immunology specialty that reflects their competence in an increasingly complex area of work and ability to use advanced diagnostic testing...
14.
Khalil S, Taha S, Al-Nesf M, Mobayed H
Qatar Med J . 2022 Aug; 2022(2):14. PMID: 35909410
Background: Aspirin-exacerbated respiratory disease (AERD) is a chronic disease characterized by chronic rhinosinusitis, nasal polyposis, asthma, and intolerance to nonsteroidal anti-inflammatory drugs (NSAIDs). Aspirin challenge is considered the gold standard...
15.
Aqel S, Ibrahim T, Taha S, Mobayed H, Al-Nesf M
Qatar Med J . 2022 Aug; 2022(2):8. PMID: 35909408
Background: Allergic rhinitis and asthma exacerbation are strongly linked to respiratory viral and bacterial infections. COVID-19 pandemic has raised concerns about the risk of infection and the severity of COVID-19...
16.
Purayil S, Mobayed H, Al-Nesf M
Qatar Med J . 2022 Aug; 2022(2):3. PMID: 35909407
Omalizumab (XOLAIR®) is a recombinant DNA-derived humanized IgG1κ monoclonal antibody that binds to IgE and was first introduced in Qatar in 2009. Omalizumab is used to treat moderate-to-severe allergic asthma...
17.
Imameldin A, Ibrahim Y, Ibrahim T, Mobayed H
Qatar Med J . 2022 Aug; 2022(2):9. PMID: 35909405
Background: Skin prick test (SPT) and intradermal test (IDT) are standard procedures in the allergy practice that are safe when performed. Individuals with a history of allergic reaction to the...
18.
Mudawi D, Taha S, Ibrahim Y, Omar M, Mobayed H
Qatar Med J . 2022 Aug; 2022(2):10. PMID: 35909400
Background: Unverified penicillin allergy has been linked to adverse patient events and increased healthcare expenditure owing to the usage of broad-spectrum, expensive antibiotics. Penicillin allergy test is the gold standard...
19.
Al-Ahmad M, Mobayed H, Al Busaidi N, Iqbal M, Al Mubaihsi S, Khadadah M, et al.
World Allergy Organ J . 2022 Jun; 15(5):100647. PMID: 35663273
Background: While crucial to the assessment and improvement of asthma control, insights on treatment practices in patients with severe diseases across Gulf nations are lacking. This observational study describes the...
20.
Al-Nesf M, Jerobin J, Al-Alawi A, El-Kassim M, Mobayed H, Mohammed T
Qatar Med J . 2019 Jul; 2019(1):1. PMID: 31321216
Hemoptysis is an alarming symptom in clinical practice. We reviewed ten years of experience with hemoptysis in a tertiary hospital in Qatar to identify hemoptysis etiologies, patient characteristics, and associated...